SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

94 hedge funds and large institutions have $53.1M invested in Syros Pharmaceuticals, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 31 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$33K
Puts
$14K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$7.46M
2
$6.58M
3
$4.96M
4
$4.17M
5
$4M
6
$3.5M
7
$2.99M
8
$2.69M
9
$2.26M
10
$2.26M
11
$1.36M
12
$1.17M
13
$1.07M
14
$975K
15
$695K
16
$609K
17
$595K
18
$579K
19
$443K
20
$297K
21
$286K
22
$263K
23
$257K
24
$227K
25
$222K